Healthcord Cryogenics

What Healthcord Cryogenics does

Healthcord Cryogenics Corporation is a privately held, 100% Canadian-owned cord blood and cord tissue bank headquartered in Vancouver, with additional offices in Calgary and Toronto, serving expectant parents across Canada since its founding in 2000. The company collects, processes, and cryogenically stores newborn hematopoietic stem cells from umbilical cord blood and mesenchymal stem cells from cord tissue, using computer-controlled rate freezing to minimize ice crystal damage and next-generation vapour phase storage tanks that suspend samples individually in liquid nitrogen vapour to eliminate cross-contamination. Operations are anchored by a coast-to-coast collection network spanning more than 450 Canadian hospitals, supported by SSL-encrypted online enrollment, phone and fax enrollment, a courier pickup-to-lab logistics chain, and physician/hospital referral flows. The business runs on a two-part revenue model: a one-time enrollment and processing fee (Premium Cord Blood & Cord Tissue at $1,795, or Cord Blood Only at $1,125) plus a storage tail priced across annual ($291), 10-year ($2,000), 20-year ($3,525), 30-year ($4,920), and lifetime ($6,850) tiers, with a 12-month installment plan to lift conversion.

Healthcord differentiates on regulatory credentials — Health Canada approval, AABB accreditation, FDA registration, and CAP Cord Blood Proficiency Testing Program participation — and on a 25-year brand narrative positioning it as Canada's largest and oldest domestic cord blood bank. Customer acquisition is multi-channel, combining educational webinars, blog and stem cell news content, social media, paid search, physician and hospital referrals, and community programs such as the Ambassador Program and Families in Need Program (free collection and storage for qualifying medical/financial cases). The product set is narrow by design: collection kits, the two core banking tiers, the storage ladder, the Families in Need assistance program, and a free information lead magnet — with no disclosed AI/ML capabilities, no API or developer platform, and no public M&A, funding, or expansion outside Canada aside from a Chinese-language portal (cn.healthcord.com). Management is not publicly named in the input data, ownership appears founder/management-controlled, and the company operates as a going concern with active website, blog, and service updates.

Name

Healthcord Cryogenics

Legal name

Healthcord Cryogenics Corporation

Website

https://healthcord.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

11–50 employees

Short description

Healthcord Cryogenics is a Vancouver-headquartered, 100% Canadian-owned private cord blood and cord tissue bank founded in 2000 that collects, processes, and cryogenically stores newborn stem cells for expectant parents across Canada via a 450+ hospital collection network and multi-tier storage plans.

Ownership category

akta.pro rank

Product category

Cord Blood and Cord Tissue Banking Services

NAICS

Blood and Organ Banks (621991), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)

akta.pro secondary industries

Cold Chain, Cryopreservation & Biologics Storage/Handling Technologies (HLAAAJAN), Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats) (HLAGAIAJ)

Keywords

• Cord blood banking
• Cord tissue banking
• Stem cell preservation
• Cryogenic storage
• Newborn stem cells

Headquarters

HQ city

Toronto

HQ country

Canada

HQ region

North America

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

1. Cord Blood Banking (Initial Enrollment): One-time enrollment and processing fee for cord blood collection, processing, and initial storage. Two tiers available: Premium Cord Blood & Cord Tissue ($1,795) or Cord Blood Only ($1,125).
2. Cord Blood Storage (Recurring): Annual and long-term storage fees: Annual ($291/year), 10 Year ($2,000), 20 Year ($3,525), 30 Year ($4,920), Lifetime ($6,850). Provides recurring revenue stream from annual storage fees.
3. Payment Plan Financing: 1 Year Financing option allowing customers to distribute payment evenly over 12 months, enabling higher customer conversion through flexible payment options.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Core offering

Healthcord Cryogenics is a Canadian private cord blood and cord tissue bank that collects, processes, and cryogenically stores newborn stem cells for expectant families across Canada. The company offers enrollment-only cord blood banking, combined cord blood and cord tissue banking, and tiered long-term cryogenic storage plans (annual to lifetime). Samples are processed using computer-controlled rate freezing and stored in next-generation vapour phase liquid nitrogen tanks at its Vancouver laboratory.

Product overview

Healthcord Cryogenics offers a private cord blood and cord tissue banking service — Canada's largest and oldest 100% Canadian cord blood bank. The core products are Premium Cord Blood & Cord Tissue Banking and Premium Cord Blood Only Banking, which collect, process, and cryogenically store newborn stem cells using computer-controlled rate freezing and next-generation vapour phase storage tanks. The service is paired with a collection kit distributed to hospitals and a mobile courier pickup system. Storage is offered across multiple duration tiers from annual to lifetime. The company also provides educational webinars, an informational pack for expectant parents, and a Families in Need Program for medically qualifying families. The products and services form an end-to-end lifecycle: enrollment → kit delivery → hospital collection → laboratory processing → cryogenic storage → certificate of banking with retrieval information.

Differentiator

Problem solved

Functional benefit

Products and services

• Premium Cord Blood & Cord Tissue Banking

Quantifiable outcome

• Over 30,000 cord blood stem cell transplants performed successfully worldwide since 1988
• +3 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators6 records

Recent moves5 records

Expansion highlights4 records

Emerging players

• Precious Cells (NOWOS): UK-based private stem cell storage company offering cord blood and cord tissue services; comparable niche player in adjacent European geography.
• Future Health Biobank: UK-based private stem cell and cord blood bank offering comparable services across cord blood, cord tissue, and broader stem cell storage.

Regional players

• Maze Cord Blood: US cord blood lab affiliated with Mount Sinai; comparable cryopreservation technology and accreditation profile, focused on the US market.
• VITA 34: Germany-headquartered private cord blood bank listed on German exchanges; comparable in service offering but focused on European geographies.

Broad incumbents

• Cryo-Cell International: US-listed cord blood and menstrual blood banking company; comparable in product offering with larger scale, public-market financials, and multi-decade operational history.
• Cord Blood Registry (CBR): Largest US private cord blood bank owned by CooperSurgical; offers the same cord blood and tissue storage services at much larger scale and serves as a reference point for Healthcord's addressable expansion.
• ViaCord: Established US private cord blood bank (PerkinElmer); offers nearly identical cord blood + cord tissue banking services to expectant parents and competes for the same end customer.

Direct peers

• Cells for Life: Canadian private cord blood and cord tissue bank with comparable direct-to-consumer model and hospital collection network; most directly comparable Canadian competitor.
• Insception Lifebank: Canadian cord blood bank offering similar private storage services with hospital-based collection; directly competes in the same Canadian DTC market.
• StemCyte: US-based cord blood bank operating both private and public banking programs; closely comparable technology and accreditation profile to Healthcord.

Market position

Strengths1 record

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/healthcord
• YouTubeyoutube.com/@healthcordcryogenics4842
• Facebookfacebook.com/Healthcord
• LinkedInlinkedin.com/company/healthcord-cryogenics
• Instagraminstagram.com/healthcord

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Healthcord Cryogenics